By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Twitter Recognizes Boehringer Ingelheim as a Pioneer
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Education > Twitter Recognizes Boehringer Ingelheim as a Pioneer
BusinessMedical EducationSocial Media

Twitter Recognizes Boehringer Ingelheim as a Pioneer

Paul Tunnah
Paul Tunnah
Share
4 Min Read
Twitter Recognizes Boehringer Ingelheim
SHARE

Twitter Recognizes Boehringer IngelheimI have written previously about how powerful I think Twitter is as a channel for a regulated industry like pharmaceuticals.

Twitter Recognizes Boehringer IngelheimI have written previously about how powerful I think Twitter is as a channel for a regulated industry like pharmaceuticals. It allows social media engagement with multiple personnel, but in controlled fashion that allows pharma companies to deal with problems in a controlled and compliant way.

Apparently one of the people who read that piece worked at Twitter and, unsurprisingly, they agreed with me!

It is great to therefore see the first business case study from the pharmaceutical industry appear on the Twitter.com website, featuring the work that social media pioneer Boehringer Ingelheim has been doing in using the social media channel to connect with other healthcare stakeholders.

More Read

Bioidentical Hormones
What Are Bioidentical Hormones Made With?
7 Viral Marketing Lessons from the ALS Ice Bucket Challenge
Four Ways to Improve Patient Satisfaction
Doctors 2.0 and You: Conference, Community, and Medical Association #doctors20
Three Biggest Pharmaceutical Lawsuits of 2012: Psychiatric Drugs Focus of All Three

The specific case study presented by Twitter is from the #COPDchat tweetchats that Boehringer Ingelheim has been running, but could equally have covered its engaging work in the atrial fibrillation or lung cancer space (which I am proud to have been involved in).

Of course, in keeping within the right regulatory guidelines that prevent direct prescription medicines promotion to patients outside the US, Boehringer’s work has focussed on tackling disease awareness issues and gathering research input from involved groups such as patient advocates, healthcare providers and disease associations, rather than discussing the merits of individual treatments.

Here, Boehringer Ingelheim outlines how it used Twitter to both approach and engage with relevant parties, positioning the discussion alongside a relevant medical conference – in this case the European Respiratory Society Congress (#ERS2013). In addition, promoted tweets were used to target specific attendees at the event, matching for keywords such as ‘asthma’ and ‘COPD’ as flags for relevance.

Links to press releases and further information were then used to provide additional background above and beyond the 140 characters permissible within a tweet, all of which sparked interest in the live tweetchat debate held during the congress.

And the results?

Well, the quantitative stats are pretty impressive. 1.7m tweetchat impressions from the hour’s live event, almost 500 mentions of Boehringer at the Congress and 1,200 new followers secured.

But the real story here is in the qualitative feedback gained from this tweetchat, and the numerous others Boehringer has run. Through such discussion the company gained valuable feedback on the market, which was spur-of-the-moment and reactive to developments at the Congress itself, in addition to opening doors with new organisations and individuals that can help its mission in the COPD space.

Twitter identified three key lessons from Boehringer’s work on tweetchats for other pharmaceutical companies:

  1. Align such online discussion with relevant offline events, like the Congress.
  2. Involve key internal stakeholders to ensure regulatory compliance.
  3. Be innovative – don’t be afraid to be the first in your sector rather than waiting for others.

With such prominence, quite rightly so, being given to Boehringer’s work it is time for other pharma companies to step up and also start driving such activities. Every pharma company is talking about being customer- and patient-focussed, and indeed the individuals working within these companies are passionate about making a difference, so communications teams need to start facilitating more of this work.

Boehringer has cut a path through the long grass for the rest of the industry. It’s time for others to start walking in their footsteps to help ensure everyone in healthcare can share their views on developing better medicines.

TAGGED:Boehringer Ingelheimpharmatwitter
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

contamination
Batch Failures And The Hidden Costs Of Contamination
Health Infographics
October 21, 2025
Medication Management For Seniors
Simplifying Medication Management For Seniors
Infographics Senior Care
October 21, 2025
Guide To Pursuing a Career in Nursing as a Foreigner in the USA
Collaboration Is the Prescription for Better Patient Care
Health
October 20, 2025
Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025

You Might also Like

Lack Of Patient-Centered Communication Skills By Physicians [infographic]

September 17, 2013
price transparency in healthcare
BusinessFinancePolicy & LawPublic Health

Seeing Through the Patient CARE Act: Why Transparency Won’t Fix Our System

March 31, 2015

Are Women Doctors Contributing to a Doctor Shortage?

June 16, 2011
2011 Google AdWords Income. Source: Wordstream
BusinessPolicy & Law

Dr. Google, I’d Like You to Meet Google Insurance Co.

July 7, 2015
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?